RSV, pneumonia drug falls into shortage

There is not enough supply for usual ordering of ribavirin inhalation solutions, a drug for severe pediatric pneumonia cases caused by respiratory syncytial virus, according to a May 23 post from the American Society of Health-System Pharmacists. 

Advertisement

Bausch Health has one solution on long-term back order and another discontinued in October, Zydus Pharmaceuticals USA has one solution with a short expiration backordered, and Cameron Pharmaceuticals could not provide information to the ASHP. 

Zydus said it expects resupply to happen in the second half of 2023, and Bausch said it could not predict a release date.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.